Addus HomeCare (ADUS) Competitors

Guardant Health (NASDAQ:GH) and Addus HomeCare (NASDAQ:ADUS) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations.

Is GH or ADUS more profitable?

Addus HomeCare has a net margin of 6.51% compared to Guardant Health's net margin of -49.93%. Addus HomeCare's return on equity of 9.39% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-49.93%	N/A	-28.95%
Addus HomeCare	6.51%	9.39%	6.86%

Does the media favor GH or ADUS?

In the previous week, Guardant Health had 2 more articles in the media than Addus HomeCare. MarketBeat recorded 11 mentions for Guardant Health and 9 mentions for Addus HomeCare. Guardant Health's average media sentiment score of 0.97 beat Addus HomeCare's score of 0.72 indicating that Guardant Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	8 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Addus HomeCare	5 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals & insiders hold more shares of GH or ADUS?

92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 95.3% of Addus HomeCare shares are owned by institutional investors. 6.1% of Guardant Health shares are owned by insiders. Comparatively, 4.5% of Addus HomeCare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Which has preferable earnings and valuation, GH or ADUS?

Addus HomeCare has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$739.02M	10.34	-$436.37M	-$3.35	-18.29
Addus HomeCare	$1.27B	1.65	$73.60M	$4.53	25.21

Which has more volatility & risk, GH or ADUS?

Guardant Health has a beta of 1.43, suggesting that its share price is 43% more volatile than the S&P 500. Comparatively, Addus HomeCare has a beta of 0.8, suggesting that its share price is 20% less volatile than the S&P 500.

Do analysts recommend GH or ADUS?

Guardant Health presently has a consensus target price of $57.50, suggesting a potential downside of 6.17%. Addus HomeCare has a consensus target price of $138.63, suggesting a potential upside of 21.41%. Given Addus HomeCare's higher probable upside, analysts clearly believe Addus HomeCare is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	0 Sell rating(s)	0 Hold rating(s)	16 Buy rating(s)	1 Strong Buy rating(s)	3.06
Addus HomeCare	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.00

Summary

Addus HomeCare beats Guardant Health on 10 of the 17 factors compared between the two stocks.